Maturity onset diabetes of the young--review
- PMID: 17551475
Maturity onset diabetes of the young--review
Erratum in
- Pediatr Endocrinol Rev. 2007 Sep;5(1):470
Abstract
Maturity onset diabetes of the young (MODY) is characterized by a primary defect in insulin secretion and hyperglycemia, nonketotic disease, monogenic autosomal dominant mode of inheritance, age at onset less than 25 years, and lack of auto-antibodies. It accounts for 2-5% of all cases of non-type 1 diabetes. The diagnosis may be made by careful clinical evaluation, but exact subtyping is possible only by genetic analysis. Several genetic factors have been identified as causative agents in MODY, each leading to a different type of the disease. These include the enzyme glucokinase, which causes MODY2, and the transcription factors HNF- 4 alpha, TCF1, I PF-1, TCF2, and NeuroD1, which cause MODY1, 3, 4, 5, and 6, respectively. The genetic findings have important clinical implications, allowing for proper genetic counseling, early diagnosis, and better care of patients.
Similar articles
-
[Non-insulin dependent diabetes in children and adolescents].Tidsskr Nor Laegeforen. 1998 Mar 10;118(7):1054-7. Tidsskr Nor Laegeforen. 1998. PMID: 9531829 Norwegian.
-
Genetic and clinical characteristics of maturity-onset diabetes of the young.Diabetes Obes Metab. 2005 Jul;7(4):318-26. doi: 10.1111/j.1463-1326.2004.00399.x. Diabetes Obes Metab. 2005. PMID: 15955117 Review.
-
[Swiss journey through the clinical and genetic characteristics of diabetes in young patients].Schweiz Med Wochenschr. 1998 Jan 31;128(5):162-6. Schweiz Med Wochenschr. 1998. PMID: 9522422 French.
-
Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.Eur J Hum Genet. 2005 Apr;13(4):422-7. doi: 10.1038/sj.ejhg.5201347. Eur J Hum Genet. 2005. PMID: 15657605
-
[Diabetes mellitus].Rinsho Byori. 2001 Feb;49(2):161-4. Rinsho Byori. 2001. PMID: 11307309 Review. Japanese.
Cited by
-
Efficacy and safety of alogliptin in a pediatric patient with maturity-onset diabetes of the young type 1.Clin Pediatr Endocrinol. 2017;26(3):183-188. doi: 10.1297/cpe.26.183. Epub 2017 Jul 27. Clin Pediatr Endocrinol. 2017. PMID: 28804210 Free PMC article.
-
Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment.Diabetes Metab Syndr Obes. 2019 Jul 8;12:1047-1056. doi: 10.2147/DMSO.S179793. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31360071 Free PMC article. Review.
-
Four Cases of Maturity Onset Diabetes of the Young (MODY) Type 5 Associated with Mutations in the Hepatocyte Nuclear Factor 1 Beta (HNF1B) Gene Presenting in a 13-Year-Old Boy and in Adult Men Aged 33, 34, and 35 Years in Poland.Am J Case Rep. 2021 Feb 2;22:e928994. doi: 10.12659/AJCR.928994. Am J Case Rep. 2021. PMID: 33526762 Free PMC article.
-
The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs.Clin Pharmacokinet. 2013 Oct;52(10):833-54. doi: 10.1007/s40262-013-0076-3. Clin Pharmacokinet. 2013. PMID: 23719679 Review.
-
Relationship between intracerebral hemorrhage and diabetes mellitus: a case-control study.J Clin Diagn Res. 2015 Apr;9(4):OC08-10. doi: 10.7860/JCDR/2015/12226.3741. Epub 2015 Apr 1. J Clin Diagn Res. 2015. PMID: 26023579 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical